Crossmark

Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline

Crossref DOI link: https://doi.org/10.1186/s13550-023-01041-x

Published Online: 2023-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tuncel, Hayel

Visser, Denise

Timmers, Tessa

Wolters, Emma E.

Ossenkoppele, Rik

van der Flier, Wiesje M.

van Berckel, Bart N. M.

Boellaard, Ronald

Golla, Sandeep S. V. http://orcid.org/0000-0002-0721-7160
Funding

Funding for this research was provided by:

Avid Radiopharmaceuticals
License Information

Text and Data Mining valid from 2023-10-27

Version of Record valid from 2023-10-27
More Information

Article History

Received: 21 February 2023

Accepted: 11 October 2023

First Online: 27 October 2023

Declarations

:

: The current study was approved by the Medical Ethics Committee of the Amsterdam University Medical Center. All subjects signed an informed consent form prior to participation. All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1975 Helsinki Declaration and its later amendments.

: Not applicable.

: No potential competing of interest relevant to this article exists.

Document is current

Any future updates will be listed below